Podcasts about fda

Meds that require special skill to start: Atomoxetine and prazosin, plus a new FDA warning on stimulants.CME: Take the CME Post-Test for this EpisodePublished On: 08/18/2028Duration: 08 minutes, 28 secondsChris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Join us for one of the most candid and honest conversations we've ever had on the podcast.... Hear our origin stories, and the truths behind how we ended up in the lifestyle. Plus, conflict that we've never discussed on the show during our first couple of years exploring non-monogamy together.... Amp up your health journey, lose weight and more with FDA approved peptides and glp-1's! Book a consultation today at https://revitaglowmeds.com Join us on Patreon for TONS of bonus content! https://patreon.com/frontporchswingers Our upcoming events: https://members.frontporchswingers.com Get 10% off Shivers gummies with code FPS at https://shivers.store Get a free month of Kasidie access! Click on the Kasidie banner at https://frontporchswingers.com  

Presented by Happy Dad Hard Seltzer. Find Happy Dad near you http://happydad.com/find (21+ only). Video is available on https://youtube.com/@onenightwithsteiny/videos. Follow Steiny on Instagram http://instagram.com/steiny. Get harder, longer-lasting erections with Ro Sparks: $15 off first order of medication to get hard at http://ro.co/steiny Compounded drugs are permitted to be prescribed under federal law but are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review by the FDA. For full safety information, go to http://ro.co/safety Part of the Shots Podcast Network (shots.com). You can listen to the audio version of this podcast on Spotify, Apple Podcasts & anywhere you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

The 5 things you need to know before the stock market opens today: Tesla is reportedly offering discounts to car leasing companies in the UK, Novo Nordisk received FDA approval for a liver disease treatment, Samsung's phone shipments to the U.S. surged in the second quarter, tech company supplier Foxconn will operate a U.S. factory as a joint venture with Softbank, OpenAI, and Oracle, and the Warner Brothers horror film “Weapons” remained number one at the weekend box office.  Squawk Box is hosted by Joe Kernen, Becky Quick and Andrew Ross Sorkin.  Follow Squawk Pod for the best moments, interviews and analysis from our TV show in an audio-first format. 

Novo Nordisk (NVO) jumped higher after the FDA approved the company's Wegovy drug as a liver disease treatment. Dayforce (DAY) rallied more than 25% off reports that Thoma Bravo is looking to acquire the company. Nvidia (NVDA) has more bullish momentum heading into next week's earnings thanks to price target hikes from Morgan Stanley and Cantor Fitzgerald. Sam Vadas explains the biggest market movers starting the trading week.======== Schwab Network ========Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

In this episode of You Are Not Broken, Dr. Kelly Casperson recaps the recent FDA event dedicated to women's health, spotlighting the critical role of hormones like testosterone and estrogen. She shares key insights from expert panels, explains why better education and prescribing practices are urgently needed among physicians, and reveals exciting details about her upcoming book on menopause. Kelly also explores the mental health impact of hormonal changes during perimenopause and offers a preview of her nationwide book tour aimed at rewriting the conversation around midlife health. Key Takeaways The You Are Not Broken podcast has surpassed 4 million downloads. The FDA event brought women's health—and hormones—into the spotlight. There is a critical need for female-dose testosterone to be recognized and approved. Changing outdated prescribing habits is key to improving women's health care. Hormones are powerful tools for preventing disease and improving quality of life. Menopause and hormonal health education remain dangerously underrepresented in medicine. Kelly's upcoming book aims to bust myths and empower women with facts. Her book tour will bring this conversation to cities across the country. Hormonal changes in perimenopause can drive significant mental health challenges. Advocacy for women's hormone therapy is essential for better health outcomes. Preorder my Next Book⁠⁠⁠ share this episode, and leave a review to help others find this important work. Let's stop leaving women out of the conversation—especially when it comes to sex, health, and healing. Listen to my Tedx Talk: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Why we need adult sex ed⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠Take my Adult Sex Ed Master Class:⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠My Website⁠⁠⁠⁠⁠⁠⁠⁠⁠ Interested in my sexual health and hormone clinic? ⁠⁠⁠⁠⁠⁠⁠⁠⁠Waitlist is open⁠⁠⁠⁠⁠⁠⁠⁠ Thanks to our sponsor ⁠⁠⁠⁠⁠⁠⁠⁠⁠Midi Women's Health⁠⁠⁠⁠⁠⁠⁠⁠⁠. Designed by midlife experts, delivered by experienced clinicians, covered by insurance.Midi is the first virtual care clinic made exclusively for women 40+. Evidence-based treatments. Personalized midlife care.⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.joinmidi.com Learn more about your ad choices. Visit podcastchoices.com/adchoices

TWiV reviews fradulent science becoming an industry, FDA may not authorize Pfizer COVID vaccine for young kids, Kennedy won't push strict pesticide regulations conserved betacoronavirus sequences recognized by human T cells, and Bispecific antibodies protect against herpes recurrent disease. Hosts: Vincent Racaniello, Alan Dove, and Brianne Barker Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Support science education at MicrobeTV Frontiers in Comparative Systems Virology Fradulent science becomes an industry (Science) FDA may not authorize Pfizer COVID vaccine for young kids (CIDRAP) Kennedy Won't Push Strict Pesticide Regulations (NY Times) Conserved betacoronavirus sequences recognized by human T cells (Cell) Bispecific antibodies protect against herpes recurrent disease (Cell Rep) Letters read on TWiV 1245 Timestamps by Jolene Ramsey. Thanks! Weekly Picks Brianne – New Study Suggests Using AI Made Doctors Less Skilled at Spotting Cancer Alan – Save the Microbes effort gets off the ground Vincent – Dr. Vinay Prasad's Catch-22: The Only Way He Can Truly Succeed at His Job is to Get Fired Again Listener Picks Chaim – “Virus Hunters” by Greer Williams Bridget – Wave Life Sciences and their potential treatment for Alpha-1 antitrypsin deficiency Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv Content in this podcast should not be construed as medical advice.

This week on Two Parents & A Podcast, we sit down with Dr. Morgan Cutlip (PhD in Psychology, relationship expert & author of ‘A Better Share: How Couples Can Tackle the Mental Load for More Fun, Less Resentment, and Great Sex') to talk all things love, parenting, and partnership. From the invisible mental load moms carry (and how it can silently kill your relationship) to why weekly marriage meetings actually work (and how to have them!!!), Dr. Morgan shares her research + real-life advice for building a relationship that thrives after kids. We also get into initiative, resentment, and her #1 secret for a long + happy marriage. If you've ever felt like you're carrying too much, wondering how to bring it up without starting World War III, or just looking for ways to reconnect with your partner—this one's for you :-)  LOVE YOU GUYS!  Timestamps: 00:00:00 Welcome back to Two Parents & A Podcast! 00:00:12 Meet Dr. Morgan Cutlip (PhD in Psychology, author and relationship expert0 00:07:15 Is mom's happiness is the key to your child's happiness? 00:13:32 What is the "mental load" and how is mismanaging it killing your relationship? 00:20:04 How to bring up the mental load conversation without starting a fight 00:25:50 The importance of a weekly relationship meeting  00:33:31 The importance of taking initiative in relationships  00:40:12 The #1 thing you need for a long and happy marriage 00:47:50 LOVE YOU GUYS!  #twoparentsandapod --------------------------------------------------------------- Thank you to our sponsors this week: *BetterHelp: As the largest online therapy provider in the world, BetterHelp can provide access to mental health professionals with a diverse variety of expertise. Our listeners get 10% off their first month at https://www.BetterHelp.com/TWOPARENTS. *Hers: Start your initial free online visit today at https://www.forhers.com/ALEX for your personalized weight loss treatment options. Hers Weight Loss is not available everywhere. Compounded products are not FDA-approved or verified for safety, effectiveness, or quality. Prescription required. Restrictions apply. Wegovy® and Ozempic® are not compounded. Actual price depends on product and plan purchased. *Pendry Newport Beach: Huge thank you to Pendry Newport Beach for hosting us for this episode. Check them out at https://www.instagram.com/pendrynewportbeach & don't miss The Elwood Club at https://www.instagram.com/elwoodclub/?hl=en — a modern members' club built on the traditions of luxury hospitality, located within Pendry Newport Beach. --------------------------------------------------------------- Listen to the pod on YouTube/Spotify/Apple: https://www.youtube.com/@twoparentsandapod https://open.spotify.com/show/7BxuZnHmNzOX9MdnzyU4bD?si=5e715ebaf9014fac https://podcasts.apple.com/us/podcast/two-parents-a-podcast/id1737442386 --------------------------------------------------------------- Follow Two Parents & A Podcast: Instagram | https://www.instagram.com/twoparentsandapod TikTok | https://www.tiktok.com/@twoparentsandapod Follow Alex Bennett: Instagram | https://www.instagram.com/justalexbennett TikTok | https://www.tiktok.com/@justalexbennett Follow Harrison Fugman: Instagram | https://www.instagram.com/harrisonfugman TikTok | https://www.tiktok.com/@harrisonfugman Find our Guest: Instagram | https://www.instagram.com/drmorgancutlip Website | https://drmorgancutlip.com/  Book | https://www.amazon.com/Better-Share-Couples-Tackle-Resentment/dp/1400239672  --------------------------------------------------------------- Powered by: Just Media House – https://www.justmediahouse.com/ --------------------------------------------------------------- Learn more about your ad choices. Visit megaphone.fm/adchoices

Hello Poison Friends! We have been covering this topic of “wellness” and the industry surrounding the term. We all want to be well, and obviously, there are some great practices out there to help us out with that, but there are also a lot of scams and misinformation out there as well. This week we are covering the story of Belle Gibson, a wellness influencer who told her followers that she had brain cancer and only had six months to live, but beat the odds using natural means and by changing her diet and lifestyle. Specifically, she promoted recipes that she would later sell in her app and cookbook (supported by Apple and Penguin Books). Belle, however, never had cancer, and while she had promised that the proceeds of her app sells would go towards various charities, she lied about that as well. She influenced many of those who did actually have cancer or chronic illness to stop conventional medicine practices such as chemotherapy, radiation therapy, medications, etc. She continued her lies for years, selling her brand and giving inconsistent medical reports along the way. It all came crumbling down with a couple of investigative journalists who received a tip that Belle might not be so sick after all. We also have to talk about Goop. Gwenyth Paltrow's brand has always been pretty controversial for most of us, but she has made a lot of money and gained a following with it. As such, we need to discuss such products and practices promoted and provided by Goop as jade eggs, amethyst bottles, and expensive stickers or yoga mats that are supposed to help a variety of issues you may deal with. She has been in legal trouble for some of her claims, but you can still find a lot of these products on her website. Just a heads up: We may mention some products with descriptions not suitable for children to hear about while discussing Goop. Nothing descriptive, mind you, or graphic, just correct anatomical terminology. A final topic for discussion this week is that of the concerning beverage being sold at convenience stores or markets called Feel Free. This product, created and sold by Botanic Tonics, has led to a lot of concern with parents and doctors, because of what is in it. One ingredient we will discuss is Kava root extract, which is not necessarily toxic in low amounts (though extracts may have some hepatotoxic effects). It is another ingredient that has been causing problems: Kratom. This ingredient is known to produce opioid-like effects (and has been considered an opioid by the FDA since 2018) and is both physiologically and psychologically addictive, causing a lot of destruction in the lives of consumers, especially those who have suffered addiction before. Let's dig into the details and have some fun learning. Thank you to all of our listeners and supporters! Please feel free to leave a comment or send us a DM for any questions, suggestions, or just to say, "hi."Support us on Patreon:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠patreon.com/thepoisonersalmanac⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Merch-⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://poisonersalmanac.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow us on socials:The Poisoner's Almanac on IG-⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/poisoners_almanac?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube-⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://youtube.com/@thepoisonersalmanac-m5q?si=16JV_ZKhpGaLyM73⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Also, look for the Poisoner's Almanac TikTok- ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@poisonersalmanacp?_t=ZT-8wdYQyXhKbm&_r=1⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Adam-⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@studiesshow?is_from_webapp=1&sender_device=pc⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Becca-⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@yobec0?is_from_webapp=1&sender_device=pc⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

On this episode of Vitality Radio, Jared is joined by Dr. Drew Kidder, VP of Education for CellCore, to unpack the fascinating science behind glutathione—often called the “master antioxidant.” They explore what glutathione is, how it supports healthy aging, mitochondrial function, and detoxification, and why modern lifestyles can leave us running low. Dr. Kidder explains the groundbreaking research on GlyNAC, a targeted blend of glycine and NAC shown to support optimal glutathione levels, and why CellCore's GlyNACtive formula goes a step further with co-factors like selenium, taurine, and bioactive carbon technology. You'll learn who may benefit most from glutathione support, how to recognize possible signs of deficiency, and practical ways to help your body produce more of this essential antioxidant naturally.Products:CellCore GlyNACtiveAdditional Information:#497: The Vital Role of Glutathione and How to Deliver it to Your Cells with Dr. Nayan PatelVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.

In his weekly clinical update, Dr. Griffin with Vincent Racaniello discusses Vijay Prasad's return to the FDA, revoking of COVID vaccine authorization for young children, the Legionnaires' outbreak in Harlem, the new labeling requirements for Ixchiq, the infectious attenuated Chikungunya vaccine and the importation of H5 influenza virus in Antarctica, before Dr. Griffin deep dives into recent statistics on RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, guidelines for treating COVID-19, whether or not the NB.1.8.1 should be included in the fall 2025 vaccines, where to find PEMGARDA, long COVID treatment center, where to go for answers to your long COVID questions, the association of “virus rebound” and post-acute sequelae among hospitalized patients, how virus infection particularly influenza and SARS-CoV-2 may ‘re-activate' dormant cancer cells and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Prasad returns to the FDA (Washington Post) Pfizer Covid vaccine for young children may not be renewed by FDA (The Guardian) Report suggests FDA may not reauthorize Pfizer COVID vaccine for young kids (CIDRAP) Factors Associated With Pediatric COVID-19 Mortality: A Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) Study (Journal of Pediatric Infectious Diseases Society) Legionnaires' Disease: In Harlem (NYC Health) Recommended Pause in Use of Ixchiq (Chikungunya Vaccine, Live) in Individuals 60 Years of Age and Older While Postmarketing Safety Reports are Investigated (FDA) FDA Removes Recommended Pause in Use and Approves Required Updated Labeling (FDA) Chikungunya Vaccines (CDC: Chikungunya virus) Chikungunya in China (CDC: Travelers' Health) Travelers' health notices (CDC: Travelers' Health) Areas at Risk for Chikungunya (CDC: Chikungunya virus) Adjuvanted recombinant zoster vaccine is effective against herpes zoster ophthalmicus, and is associated with lower risk of acute myocardial infarction and stroke in adults aged ≥50 years (CID) Tracking HPAIV H5 through a geographic survey of Antarctic seabird populations (Scientific Reports) Report details first suspected H5 avian flu detections in seabirds in Antarctica(CIDRAP) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) FDA-CDC-DOD: 2025-2046 influenza vaccine composition (FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) ENFLONSIA: novel drug approvals 2025 (FDA) RSV-Network (CDC Respiratory Syncytial virus Infection) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness (CID) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Paxlovid (Pfizer) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Steroids,dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID TWiV 1243: Capitalism, COVID and Cancer (MicrobeTV) Respiratory viral infections awaken metastatic breast cancer cells in lungs(Nature) Reaching out to US house representative Letters read on TWiV 1244 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

About this episode: Fall vaccines for flu, RSV, and—more recently—COVID have long followed a uniform rollout schedule allowing clinics and pharmacies ample time to order and administer shots. But that process looks different this year, raising concerns about access. In this episode: Katelyn Jetelina, publisher of Your Local Epidemiologist, explains how changes to the CDC's Advisory Committee on Immunization Practices (ACIP) and the FDA are pushing back the timeline and changing recommendations for routine vaccinations. Guest: Katelyn Jetelina, PhD, MPH, is an epidemiologist and scientific communicator. She is the co-founder of Health Trust Initiative, an adjunct professor at Yale School of Public Health, and a Senior Scientific Advisor to several government and non-profit agencies, including the CDC. In addition, Jetelina is the publisher of Your Local Epidemiologist. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: What's the plan for fall vaccines? If you're confused, you're not alone—Your Local Epidemiologist Covid cases rising in US as officials plan to restrict booster vaccines—The Guardian Will New Vaccine Recommendations Affect Your Fall Flu Shot?—AARP Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Nicotine, NDT Bans, and the Truth Big Pharma Doesn't Want You to Hear In this episode, I sit down with Dr. Bryan Ardis to challenge the mainstream narrative on nicotine and expose what's really behind the push to ban it worldwide. Backed by history, published research, and clinical data, Dr. Ardis explains how nicotine may support recovery from long COVID, reduce inflammation, improve autoimmune conditions, sharpen brain function, and even play a role in cancer prevention. We also cover the FDA's plan to ban natural desiccated thyroid medications and how it connects to larger efforts to restrict patient access to bioidentical hormones and other natural treatments. Dr. Ardis breaks down the financial and political forces at play, and I share my own cancer experience and how this information could shift your approach after a diagnosis. If you're ready to hear the research, the risks, and the real reasons behind these bans, this conversation will give you the clarity you need to protect your health and your options. Connect with Dr. Bryan Ardis: Website/Book: https://thedrardisshow.com/beyond-c-19-lies-book/#video Book on Amazon: ⁠Moving Beyond the CoVid 19 Lies⁠ Fall Conference: https://www.healingfortheages.com/2025-ages-fall-conference/ WHAT DO MY LABS MEAN?! Try the ultimate tool to Decode Your Labs: Understand your thyroid, hormones, and blood sugar numbers to transform your health https://dramie.com/labs/ We prescribe to all 50 states!  When you're ready to FINALLY get the help you deserve… Book a free application call: https://dramie.com/book-a-call/ Shop ALL of Dr. Amie's Fixxr® Supplements: https://betterlifedoctor.com/ EARN CE Credits: "Nurses, hold-on  – here comes the exciting part: you can earn nursing CE credits by listening to our podcasts! That's right—RNegade has teamed up with podcast hosts like me who are delivering amazing content that doesn't limit you to “thinking outside-the box,” it challenges you to BLOW-UP the box by learning from innovators, pioneers, and RENEGADES in the field of health and medicine WHILE EARNING YOUR CEs!” https://rnegade.thinkific.com/?ref=4d98d0 RATE, REVIEW AND FOLLOW ON APPLE PODCASTS If you made it this far I'm impressed! That means you really love the show and I love you for that!  So I'm going to ask you for a favor. Would you please leave a quick review or even 5⭐️. I DO read them and can't tell you how much I appreciate it! Thank you in advance!❤️  Just click here it's quick and easy : https://podcasts.apple.com/us/podcast/the-thyroid-fixer/id1529800263,  Ok ONE MORE favor…would you please subscribe and follow the show? This is a win-win! It tells the podcast powers that be that you like The Thyroid Fixer Podcast AND it lets you catch all the new episodes that come out every week. Follow with this link: https://podcasts.apple.com/us/podcast/the-thyroid-fixer/id1529800263 and never miss out on a moment of the journey! CONNECT WITH ME ON SOCIAL MEDIA: Want to get your labs reviewed and your questions answered LIVE by me? Join my exclusive Facebook group, Just Fix Your Thyroid – a supportive and empowering community designed to give you the tools, guidance, and HOPE you need on your thyroid and hormone journey.

There's a lot of fear and misinformation around HRT, and one of the biggest myths is that HT is a highly significant cause of breast cancer. That is not the case. This is a remnant concept from 2002, with MANY caveats. Calls for the removal of the black box warning on hormone replacement therapy (HRT) stems primarily from the outdated and limited nature of the data from the Women's Health Initiative (WHI) study published in 2002. The WHI, while groundbreaking at the time, focused predominantly on a specific formulation of conjugated equine estrogens (CEE) and medroxyprogesterone acetate (MPA) in older, postmenopausal women, leading to concerns about its generalizability to the broader population of women considering HRT. This is why on July 17, 2025, the FDA met with a panel of experts, in open forum, to hear the petition of removing the black box warning on hormone replacement therapy. Listen in for details. 1. Writing Group for the Women's Health Initiative Investigators. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial. JAMA.2002;288(3):321–333. doi:10.1001/jama.288.3.3212. Manson JE, Crandall CJ, Rossouw JE, Chlebowski RT, Anderson GL, Stefanick ML, Aragaki AK, Cauley JA, Wells GL, LaCroix AZ, Thomson CA, Neuhouser ML, Van Horn L, Kooperberg C, Howard BV, Tinker LF, Wactawski-Wende J, Shumaker SA, Prentice RL. The Women's Health Initiative Randomized Trials and Clinical Practice: A Review. JAMA. 2024 May 28;331(20):1748-1760. doi: 10.1001/jama.2024.6542. PMID: 38691368.3. NAMS: The 2022 hormone therapy position statement of The North American Menopause Society (Menopause)

This week's health headlines: Medicaid changes, FDA hormone panel, and what it might mean for you. Amy Stuttle is joined by Dr. David Yablonsky to unpack two hot-button healthcare topics making headlines. First, they break down Trump's “Big Beautiful Bill” and its proposed Medicaid work requirements discussing how it could impact patients, hospitals, and taxpayers, and exploring potential solutions for breaking cycles of poverty. Then, they shift to the FDA's recent panel on women's hormone therapy, including the push to remove outdated black box warnings from estrogen and progesterone, the knowledge gap in menopause care, and why bio-identical hormones could be a game-changer for women's health. Victory Men's Health Click Here Victory Men's Health YouTube For questions email podcast@amystuttle.com Disclaimer: The Women Want Strong Men Podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

 It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: cancer reserach may lead to T1D treatment, GLP-1 oral pill moves forward, Tandem pharmacy moves, Medtronic-Abbott sensor unveield, parents of kids with T1D see income drop, Mannkind submits Afrezza for pediatrics, diabetes scholarships and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Cornell researchers have developed an implant system that can treat type 1 diabetes by supplying extra oxygen to densely packed insulin-secreting cells, without the need for immunosuppression. The system could also potentially provide long-term treatment for a range of chronic diseases. This lab has produced previous implantable devices that have proved effective in controlling blood sugar in diabetic mice, but they can only last so long. "It's the proof of concept. We really proved that oxygenation is important, and oxygenation will support high cell-density capsules," Tempelman said. "The capsules are immune protective and last for a long time without having some kind of fouling of the membrane. The body never likes it when you put a foreign substance in. So that's the engineering in the Ma Lab, to look for materials and coatings for the materials that are immune protective, but also don't invoke excess response from the body because of the material." The next step will be to implant the system in a pig model, and also test it with human stem cells. The researchers are interested in eventually trying to use the system for implanting different cell types in humans for long-term treatment of chronic diseases, according to Tempelman, who is CEO of Persista Bio Inc., a new startup she founded with Ma and Flanders that is licensing these technologies. https://medicalxpress.com/news/2025-08-implant-diabetes-oxygenating-insulin-cells.html XX Mayo Clinic cancer research may be big news for T1D. After identifying a sugar molecule that cancer cells use on their surfaces to hide from the immune system, the researchers have found the same molecule may eventually help in the treatment of type 1. Cancer cells use a variety of methods to evade immune response, including coating themselves in a sugar molecule known as sialic acid. The researchers found in a preclinical model of type 1 diabetes that it's possible to dress up beta cells with the same sugar molecule, enabling the immune system to tolerate the cells. The findings show that it's possible to engineer beta cells that do not prompt an immune response   In the preclinical models, the team found that the engineered cells were 90% effective in preventing the development of type 1 diabetes. The beta cells that are typically destroyed by the immune system in type 1 diabetes were preserved.     https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-find-sugar-coating-cells-can-protect-those-typically-destroyed-in-type-1-diabetes/ XX A daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as the popular injectable drugs Mounjaro and Ozempic, according to results of a clinical trial announced by Eli Lilly on Thursday morning.   The drug, orforglipron, is a GLP-1, a class of drugs that have become blockbusters because of their weight-loss effects. But the GLP-1s on the market now are expensive, must be kept refrigerated and must be injected. A pill that produces similar results has the potential to become far more widely used, though it is also expected to be expensive.   Lilly said it would seek approval from the Food and Drug Administration later this year to market orforglipron for obesity and early in 2026 for diabetes. https://www.nytimes.com/2025/04/17/health/pill-glp-1-eli-lilly.html XX Use of diabetes technology has dramatically increased and glycemic control has improved among people with type 1 diabetes (T1D) in the US over the past 15 years, but at the same time, overall achievement of an A1c level < 7% remains low and socioeconomic and racial disparities have widened. These findings came from an analysis of national electronic health records of nearly 200,000 children and adults with T1D by Michael Fang, PhD, of the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues. The study was published online on August 11, 2025, in JAMA Network Open. Use of continuous glucose monitors (CGMs) increased substantially from 2009-2011 to 2021-2023, from less than 5% in both children and adults to more than 80% and over half, respectively. While A1c levels did drop over the 15 years, just 1 in 5 children and slightly over a quarter of adults achieved a level < 7%. The average A1c level stayed above 8%, with ethnic minorities and low-income patients seeing the smallest gains.       https://www.medscape.com/viewarticle/diabetes-tech-use-rise-a1c-reductions-still-lag-2025a1000lc9 XX Inflammation may predict how well people with diabetes respond to depression treatment, and the effects differ dramatically between type 1 and type 2 diabetes. Diabetes and depression often appear together. Indeed, depression is more than three times more prevalent in people with type 1 diabetes (T1D) and nearly twice as prevalent in people with type 2 diabetes (T2D). When they appear together, treatment for depression can vary widely. In a new study, researchers from the German Diabetes Center (DDZ), the Research Institute of the Diabetes Academy Mergentheim (FIDAM), and the German Center for Diabetes Research (DZD) investigated how inflammation in the body relates to improvement in depression symptoms in people with T1D and T2D. The researchers combined data from three previous German randomized clinical trials that aimed to reduce elevated depressive symptoms and diabetes distress in people with type 1 or type 2 diabetes. Diabetes distress is characterized by feelings of overwhelm, frustration, guilt and worry about diabetes management and its potential complications. A total of 332 participants with T1D and 189 with T2D who had completed both a baseline and 12-month follow-up examination were included in the present study. Measures included depression using the Center for Epidemiological Studies Depression scale (CES-D), blood tests for 76 inflammatory biomarkers, and symptoms broken down into cognitive-affective (e.g., feeling hopeless), somatic (e.g., poor sleep, fatigue), and anhedonia (loss of pleasure) clusters.   After adjusting for factors like age, body mass index (BMI), diabetes duration, cholesterol, and co-existing illnesses, the researchers found that in patients with T1D, higher baseline inflammation was linked to smaller improvements in depression. Inflammation seemed to be more connected to physical/somatic symptoms in T1D patients. In those with T2D, higher baseline inflammation was linked to greater improvements in depression. For these patients, the effect was strongest for cognitive-affective and anhedonia – so, emotional and motivational – symptoms.   The researchers weren't sure what caused the difference between T1D and T2D, but they suggest it might be due to the different forms of immune activation seen in each condition. That is, autoimmune processes in type 1 and metabolic inflammation in type 2. https://newatlas.com/health-wellbeing/inflammation-diabetes-depression-treatment/ XX Parents of children diagnosed with type 1 diabetes suffer an income drop in the years following the diagnosis. The impact is more pronounced in mothers, especially mothers of children diagnosed in preschool years. And these findings come from a European study.. not the US. Previous research has shown that parents of children with type 1 diabetes are at increased risk of stress-related symptoms and may need to reduce their working hours. "In our study, we observed reduced parental work-related incomes in the years following the child's type 1 diabetes diagnosis. The drop was larger in mothers than in fathers. Since mothers earned significantly less than fathers in absolute terms, even before the child fell ill, the relative drop in mothers was 6.6% the year following diagnosis compared to 1.5% in fathers. We further note the greatest impact on work-related incomes in mothers of children diagnosed at preschool age," says Beatrice Kennedy, physician at the Endocrine and Diabetes unit at Uppsala University Hospital and Associate Professor of Medical Epidemiology at Uppsala University, who led the study. This is a huge study, builds on data from national population and health registers and the Swedish Child Diabetes Register (Swediabkids). The study includes the parents of more than 13,000 children diagnosed with type 1 diabetes in Sweden in 1993−2014, as well as more than half a million parents in the general population who have children not diagnosed with diabetes.   The researchers observed that the maternal pension-qualifying incomes (a composite outcome including work-related income and societal benefits) initially increased after the child's diagnosis. This was attributable to mothers applying for the parental care allowance from the Swedish Social Insurance Agency. The parental care allowance was intended to compensate for disease-related loss of work-related income and contribute toward disease-specific costs.   When the research team investigated long-term effects in mothers, they found that the pension-qualifying incomes gradually decreased after eight years, and had not recovered by the end of follow-up − 17 years after the children were diagnosed. https://www.news-medical.net/news/20250811/Mothers-face-greater-financial-impact-following-childe28099s-type-1-diabetes-diagnosis.aspx XX The U.S. Department of Justice has reached a settlement with Metro Nashville Public Schools after allegations that the district violated the Americans with Disabilities Act.   The parents of a student at the Ross Early Learning Center requested that the school monitor their child's glucose monitor. Investigators found the school refused to do so, despite the child's Type 1 Diabetes diagnosis.   As part of the settlement, MNPS agreed to change its policies to allow the use of these devices, ensure trained staff can monitor them throughout the entire school day and at school activities, and improve communication with parents. https://www.wsmv.com/2025/08/12/metro-nashville-public-schools-settles-allegations-it-discriminated-against-students-with-diabetes/ XX Modular Medical has unveiled Pivot, its next-generation insulin patch pump technology aimed at simplifying diabetes care. The company announced its new pump for “almost-pumpers” at the Association of Diabetes Care & Education Specialists (“ADCES”) Conference in Phoenix, Arizona this weekend. It aims for Pivot to target adults with a user-friendly, affordable design.   Modular Medical's current pump, the MODD1, won FDA clearance nearly a year ago. It features new microfluidics technology to allow for the low-cost pumping of insulin. The system has a reservoir size of 300 units/3mL. Users can monitor the pump activity with their cell phone and do not require an external controller. The pump uses a provided, single-use, disposable battery.   The company announced recently that it validated its insulin pump cartridge line for human-use production in the U.S. Days later, it reported the first human use of the MODD1 pump.   Now, it has taken the next steps with the debut of a next-gen pump, set for FDA submission in October.   Modular Medical also gamifies diabetes care The company also said ADCES is the place where it will showcase the first playable level of its new Pivot pump gamified trainin module. Level Ex, a developer of medical games, develops the module.   Modular Medical said gamification offers a way to make medical training more effective and efficient while improving information retention. Given the complexity in pump uptake, the company hopes to provide an easy way to bring its technology to clinicians and patients.   The company expects to have training modules available at the same time as the pump's planned launch in 2026.   “Level One is free because diabetes mastery shouldn't come with a price tag,” Sam Glassenberg, CEO of Level Ex, said. “Modular Medical is breaking barriers too – bringing pump therapy to more people through smart, accessible design. Together, we intend to make diabetes management simpler and more inclusive.   “People learn best through play – and we believe they want to learn about insulin pumps the same way. In Level One, players aren't just mastering diabetes management through gameplay – they're asking to ‘play' with pumps: to explore how they work, understand their benefits, and build confidence before using them in real life. Our partnership with Modular Medical helps make that possible.” https://www.drugdeliverybusiness.com/modular-medical-unveils-next-gen-insulin-pump/ XX On Tuesday, 12 August 2025, Tandem Diabetes Care (NASDAQ:TNDM) presented at the Canaccord Genuity's 45th Annual Growth Conference, outlining strategic shifts and market focus. The company highlighted its plans for commercial transformation in the U.S. and expansion in international markets, alongside addressing competitive challenges and regulatory impacts. While optimistic about growth in Outside the U.S. (OUS) markets, Tandem is navigating a more competitive landscape domestically. We have entered into the pharmacy channel with Mobi only. And so as Mobi's been building up volume, we're getting experience and we're really learning and understanding what pharmacy offers to us. And the proof points have proved out the thesis I said earlier, which is it can really reduce that barrier for patients, is the out of pocket cost. And so we've decided to accelerate our strategy and where we were starting just with Mobi, we are now moving t slim supplies into the pharmacy channel, and that will kick into gear in the fourth quarter. So as people are looking at the cadence of sales for the remainder of the year with this reframing, many folks are seeing what looks like a a might be an outsized fourth quarter and and having trouble understanding those dynamics. We'll be adding the tSIM supplies to those contracts. We also have more coverage. We will have it in the coming weeks effective this year, so we will be increasing that 30% rate before the end of the year. And then, obviously, everyone's in the same cycle right now already negotiating and discussing their 2026 coverage. And so 30% is the floor.   We do expect to continue to grow that coverage in the coming years, and ultimately have a much broader access. Absolutely. It's an exciting technology that allows for us to have an infusion set that extends the wear time from three days to up to seven days. So we're able to use that as part of an independent infusion set, which would then be used with the t slim and with the mobi pump today. But we're also using that same technology as part of the site that's used for mobi when you use it with a tubeless cartridge. So next year, we will launch Mobi in a patch configuration.   It uses the same pump that's available today, but by using a modified cartridge, you're able to wear it as a patch pump. So one of the things we announced on the call is that we're using this extended wear technology as part of that site. So what it allows you to do is to change the portion that you wear in your skin separate from the timing of when you change the insulin cartridge. So it allows for that extended wear time, reduction of burden to the patient, which is especially important for higher volume insulin users as we expand into type two. So from here, we will launch the extended wear site next year along with we'll do a separate regulatory filing for the cartridge portion for Mobi that includes this extended wear technology as a predicate device. So that's another filing that we'll need to do, but we have the clearance today for the independent infusion set, but we'll file another five ten k for use of the extended wear technology as part of the tubeless Mobi feature. https://za.investing.com/news/transcripts/tandem-diabetes-at-canaccord-conference-strategic-shifts-and-market-focus-93CH-3834464 XX MannKind today announced a significant regulatory submission and a large financing agreement with Blackstone. The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said.   First, the Danbury, Connecticut-based company announced that it submitted a supplemental Biologics License Application (sBLA) for Afrezza, its inhaled insulin product, in the pediatric population.   MannKind Director of Medical and Scientific Engagement Joanne Rinker, MS, RDN, BC-ADM, CDCES, LDN, FADCES, told Drug Delivery Business News at ADA 2025 that a submission was on the way for children and adolescents aged 4-17 years old. Further data shared at ADA found Afrezza both safe and effective in that age range.   Afrezza is a fast-acting insulin formulation delivered through an inhaler device. MannKind engineered the mechanical inhaler device to slowly bring powder into the lung. A small compartment opens for the insertion of the insulin cartridge, then the user closes it. The only other component is a mouthpiece for the sake of cleanliness. Then, the inhalation takes just two seconds. It requires no electronics or extra components.   The company expects a review acceptance decision early in the fourth quarter of 2025.   “The submission of our supplemental Biologics License Application (sBLA) for Afrezza in pediatric patients is a meaningful milestone for MannKind and people living with diabetes,” said Michael Castagna, CEO of MannKind Corporation.   Additional funding provides a significant boost for MannKind MannKind also announced a strategic financing agreement with funds managed by Blackstone worth up to $500 million. The financing provides MannKind with non-dilutive capital to advance its short- and long-term growth strategies.   This senior secured credit facility includes a $75 million initial term loan funded at closing. It then has a $125 million delayed draw term loan available for the next 24 months. Finally, it features an additional $300 million uncommitted delayed draw term loan available at the mutual consent of MannKind and Blackstone.   The facility bears interest at a calculated SOFR variable rate plus 4.75% and matures in August 2030.   “This strategic financing significantly increases our operating flexibility and provides us substantial access to non-dilutive capital on favorable terms, complementing our strong cash position,” said Castagna. “The funding will support the expansion of our commercial team in preparation for the anticipated launch of the pediatric indication for Afrezza, if approved, continued pipeline advancement, potential business development opportunities, and general corporate purposes. Partnering with the Blackstone team on this transaction positions us to accelerate our next phase of growth and innovation.” https://www.drugdeliverybusiness.com/mannkind-fda-submission-pediatrics-500m-blackstone/ XX   Medtronic MiniMed Abbott Instinct Sensor [Image from Medtronic Diabetes on LinkedIn] The Medtronic Diabetes business today took to social media to share an early preview of a new integrated Abbott sensor for its insulin delivery systems. Medtronic Diabetes — soon to be MiniMed after its planned separation from the medtech giant – said in the post that the new sensor specifically designed for its own systems is called “Instinct.”   “Get a sneak peek at what's coming next: the Instinct sensor,” the business unit's account wrote. “Made by Abbott, the Instinct sensor is designed exclusively for MiniMed systems. We'll share more details about the Instinct sensor when it's commercially available.”   The sensor, built on the Abbott FreeStyle Libre platform, reflects “the power of the partnership,” Abbott EVP, Diabetes Care, Chris Scoggins, told Drug Delivery Business News earlier this year.   Medtronic and Abbott — two of the largest diabetes tech companies in the world — announced a year ago that they entered into a global partnership pairing Abbott continuous glucose monitors (CGMs) with Medtronic insulin delivery systems.   The partnership aims to collaborate on a system based on Abbott's FreeStyle Libre CGMs with Medtronic's automated insulin delivery technology (the latest generation being the MiniMed 780G) and smart insulin pen systems, such as the InPen system.   Read more about Medtronic, Abbott and the rest of the diabetes tech industry in our free Diabetes Technology Special Report. Medtronic's systems previously used its own CGMs, such as the Guardian 4 and the Simplera platform, and the company intends to continue using those systems as part of a comprehensive CGM portfolio. Under the companies' agreement, the systems would be sold exclusively by Medtronic — including the Abbott CGM.   The companies brought the partnership a step further in April when Medtronic announced the submission of an interoperable pump with the Abbott sensor technology to the FDA. They plan to share more details following the expected FDA clearance, which remains pending.   Management also recently emphasized the multi-year nature of the partnership, meaning Medtronic could pair current and future pumps with other Abbott sensors in the future. That could hint at integration with the company's future dual glucose-ketone monitor, as a number of pump makers have already announced collaborations to pair their systems with the sensor once it hits the market. https://www.drugdeliverybusiness.com/medtronic-diabetes-previews-abbott-sensor-minimed/ XX Governor Glenn Youngkin joined Civica officials at the company's Petersburg manufacturing facility to announce a $3 million grant from the Commonwealth of Virginia to accelerate Civica's efforts to develop and produce affordable insulin for Americans living with diabetes.   CivicaRx Logo   "We are proud to partner with Civica in their mission to make essential medicines more accessible," said Governor Youngkin. "This investment reflects our belief in the power of public-private collaboration to improve lives and strengthen communities."   These funds will support the production of insulin aspart, a rapid-acting human insulin analog used to regulate blood sugar in adults and children with diabetes. Civica plans to produce both rapid- and long-acting insulins at its state-of-the-art manufacturing facility in Petersburg, Va., where the company now employs more than 200 skilled workers.1 Over 8 million people living with diabetes need rapid-acting and/or long-acting insulin.   The Governor also announced that he had officially proclaimed August 7 – 14 2025 'Life Sciences Week' demonstrating the Commonwealth's commitment to "accelerating the advancement of the life sciences through public-private partnerships, STEM education, workforce development, and sustained investment in research and development."   "We are grateful for the Commonwealth's support," said Ned McCoy, Civica's President and CEO. "This funding will help us move closer toward our goal of ensuring that no one has to choose between insulin and other basic needs."   Civica and Virginia officials were joined by Lynn Starr, Chief Global Advocacy Officer of Breakthrough T1D, the leading global type 1 diabetes research and advocacy organization.   "More than one million American adults live with type 1 diabetes, and many still, sadly, ration their insulin, due to the prohibitively high cost of this necessary medication," said Starr.  "Civica's work will help to make insulin more affordable for people across the country."   Breakthrough T1D is among more than two dozen organizations and philanthropists, along with the states of Virginia and California, that have partnered with Civica to support the development of affordable insulins.   Civica's insulin initiative aims to provide patients with predictable, transparent pricing — no more than $30 per vial or $55 for a box of five pens — regardless of insurance status.   About Civica Civica is a nonprofit pharmaceutical company established to address drug shortages. It was founded by a group of U.S. health systems and philanthropies who, after more than a decade of chronic shortages, recognized that the market was not self-correcting and that a different approach is required. Civica works to deliver a safe, stable, and affordable supply of essential medicines to U.S. patients.   Media Contact: Liz Power liz.power@civicarx.org +1 860 501 3849 https://cbs4indy.com/business/press-releases/cision/20250807NY46213/governor-glenn-youngkin-announces-3-million-grant-to-support-civicas-affordable-insulin-programs/ XX If you or someone you love is living with diabetes, you already know the fight isn't just medical—it's financial, too. Between daily supplies, doctor visits, and long-term care, the cost of managing type 1 or type 2 diabetes can be overwhelming. Add college or trade school into the equation, and suddenly staying healthy competes with building a future. That's where scholarships for students with diabetes—like Beyond Scholars and others listed here—step in.   Whether you're headed to a university, a two-year college, or a hands-on trade program, these opportunities were created to ease the load.   Scholarships for students with diabetes Beyond Scholars (from Beyond Type 1): $10,000 for recently graduated high school seniors with type 1 diabetes or type 2 diabetes entering college or trade school. This is one of the largest needs-based diabetes scholarships in the United States. This year, awardees will also receive 6 months of wellness coaching through Risely Health.   Applications open: July 25, 2025 Deadline: August 29, 2025 Winners announced: October 2025 https://beyondtype1.org/beyond-scholars-diabetes-scholarships-college-trade-school/ XX Nick Jonas and Kyle Rudolph are using their platforms for a good cause.   On Tuesday, Aug. 12, the singer and the former NFL tight end (via his professional fundraising platform Alltroo) announced they're teaming up to launch a rally featuring a fan-coveted prize: a custom 2025 Volkswagen ID. Buzz electric bus that the Jonas Brothers have brought along for their 20th anniversary tour.   “Ten years ago, we hit the road with a goal to change what it means to live with diabetes. Since then, Beyond Type 1 has grown into the world's largest digital diabetes community, offering the tools, education, and peer support needed to not only survive but thrive with diabetes,” Jonas, who co-founded Beyond Type 1 (a nonprofit that advocates for those living with diabetes), says in a statement.     “We've challenged stigma, built community, provided life-saving resources, and collectively driven global innovation toward prevention and cure. This milestone is a moment to rally even more support for our mission, and partnering with Alltroo helps us do that in a powerful, engaging way.”   Related Stories Nick Jonas on Managing His Diabetes: 'The Mental and Emotional Health Aspect Is Really Important' nick jonas Nick Jonas Says He Was Diagnosed with Diabetes After Joe Told Their Parents: 'Something's Really Wrong' Joe Jonas and Nick Jonas attend the amfAR Cannes Gala 30th edition at Hotel du Cap-Eden-Roc on May 23, 2024 For Rudolph, the campaign is about "celebrating Beyond Type 1's incredible work over the past decade, and standing behind their vision of a world where everyone with diabetes — or at risk of it — has access to the knowledge, care and support needed for early diagnosis and lifelong health."   While the rally is live on Alltroo.com, fans can also scan QR codes available at all 36 Jonas Brothers concert stops to enter for a chance to win the electric bus. (A winner will be selected on November 14, which is World Diabetes Day.)   Jonas, 32, has long been open about his Type 1 diabetes diagnosis at 13 years old. "I had this kind of wrench thrown into things when I was diagnosed and it took a while to figure out how to count carbs to properly dose for insulin and what things would affect me in different ways," he previously told PEOPLE.   "When I was first diagnosed, I was sitting in the hospital and was scared to death, honestly, while I was learning about how to manage this new thing I was dealing with," Jonas recalled. "It would have been amazing to have someone to look at at that time to say, oh, this is a person living with it and they're following their dreams. They're doing what they want to do with their lives and not letting it slow them down."           https://people.com/nick-jonas-kyle-rudolph-launch-fan-rally-diabetes-awareness-11788684

In this episode, Dr. Tracy Beth Hoeg discusses the implications of SSRIs during pregnancy, the role of serotonin in fetal development, and the importance of transparency in FDA communications. The conversation also touches on the hormone therapy debate, the issue of over-medication in society, and the need for a focus on root causes in treatment approaches. The Tudor Dixon Podcast is part of the Clay Travis & Buck Sexton Podcast Network. For more visit TudorDixonPodcast.com Watch The Tudor Dixon Podcast on RumbleSee omnystudio.com/listener for privacy information.

The digital landscape is evolving at breakneck speed, and with it comes a host of unexpected consequences that blur the lines between helpful innovation and concerning overreach. In this eye-opening episode, we examine how AI is creeping into spaces where human judgment and empathy might better serve us.A troubling new wave of voice phishing attacks has emerged, with cybercriminals using AI to perfectly mimic human voices in real-time conversations. Even tech giant Google fell victim to this sophisticated approach when the notorious Shiny Hunters group breached their Salesforce CRM instance. The days of obvious phishing emails are behind us – now your boss's voice on the phone might actually be an AI impersonation designed to extract sensitive information.Our special guest Nick Espinoza joins us to unpack the fascinating world of AI competitions, revealing how OpenAI's model recently outperformed Elon Musk's Grok in a chess tournament. But the conversation takes a more serious turn when we discuss government pushes for backdoor access to AI chips – ostensibly for security, but creating vulnerabilities that could be exploited. Most alarming is the FDA's implementation of AI in drug approval processes, with former employees reporting the system hallucinating non-existent studies and misrepresenting research.The human cost of AI overreach becomes clear when we explore the growing trend of using chatbots for psychological support. As one journalist discovered when using ChatGPT for couples counseling, these systems lack the empathy and insight necessary for therapeutic work, exhibiting "sycophancy" by agreeing with users rather than providing objective guidance. On a lighter note, we tackle Nintendo's official announcement that Mario has been friend-zoned by Princess Peach after four decades of rescue missions, and share the tale of a man who successfully sued Google after Street View captured him naked in his private backyard despite having a tall privacy wall.Pour yourself a glass and join us as we taste Still Austin Straight Rye whiskey while navigating the complex intersection of technology, privacy, and human connection in our rapidly evolving digital world.Support the show

We love to hear from our listeners. Send us a message.Episode 2 of FDA Fridays, the special series from Cell & Gene: The Podcast, features Host Erin Harris' discussion with regulatory expert Monika Swietlicka, Principal, Regulatory Strategy, Halloran Consulting Group about the key strategies and challenges in navigating FDA regulation for cell and gene therapies. Their conversation covers the importance of defining a therapy's intended role (curative, chronic, or adjunctive) early in development, the different regulatory expectations based on disease context and patient population, and the crucial impact of unmet medical need on regulatory flexibility. Swietlicka emphasizes the necessity of a clear, scientifically sound regulatory narrative, especially when precedent is lacking, and advocates for early, robust investment in CMC to minimize risks. They also explore the complexities of using surrogate endpoints, planning for long-term patient follow-up under uncertainty, and the value of integrating commercial considerations from the outset. Swietlicka calls for cell and gene therapy developers to adopt a commercial mindset and proactive regulatory engagement to achieve clinical and commercial success.Subscribe to the podcast!Apple | Spotify | YouTube Visit my website: Cell & Gene Connect with me on LinkedIn

The drug maker Merck recently announced its plans to start two new trials, known as the EXPrESSIVE program, testing a monthly pill for PrEP. A once-a-month PrEP pill holds great potential for the field. Even with daily pills, a monthly ring, or long acting injectables such as cabotegravir and recently FDA-approved lenacapavir, there'll be people who can't find what they really need for prevention.    For advocates who follow prevention, there's a lot to know about these trials, and powerful lessons to learn about Good Participatory Practice (GPP) and impactful involvement of stakeholders—especially community—in research. GPP has been a cornerstone of the process of design and protocol development for the EXPrESSIVE trials, and it doesn't stop there.   This episode features Merck Senior Principal Scientist Rebeca Plank and AVAC's Regional Manager for Research Engagement Grace Kumwenda. They explain why a monthly pill could be so important to HIV prevention and how GPP is shaping the design and rollout of the trials. 

The FDA's new AI is being inserted into the approval process for new medications and it's been caught fabricating studies, misinterpreting meeting conversations and worse... and RFK Jr. wants to use it to speed up the approval process! On top of this, it looks like airlines want to sell our biometrics, a new privacy nightmare of a US Health Database is being built and your AI therapist has no privacy protections. We explore ALL of this and so much more... don't miss this one!

The FDA recently put out a report stating that Children receive more than 60 % of their calories from UPFs - Ultra Processed Foods. UPFs contain industrial formulations including chemicals, manufactured sweeteners, flavor enhancers, colorants, emulsifiers, thickeners, anti-foaming agents, bulking or gelling agents—to make them highly palatable, visually appealing, and shelf-stable. That all happens to also make food highly toxic to our bodies. It's no wonder why almost 20% of our children are obese and trends put that number growing annually.   So WHY has this mock-food been allowed - and WHAT can we do about it? That's what the BrainStim gang is delving into in today's epsiode. We hope you listen and start a health revolution in your town to change the generational cycle of sickness.   As always, if you want more information or have questions, please visit us at www.invisionchiropractic.com. 

BUFFALO, NY – August 15, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on August 13, 2025, titled “Clinical and analytical validation of MI Cancer Seek®, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assay.” In this study, first authors Valeriy Domenyuk and Kasey Benson, along with corresponding author David Spetzler from Caris Life Sciences in Irving, Texas, introduce MI Cancer Seek, an FDA-approved test designed to deliver comprehensive tumor profiling. MI Cancer Seek demonstrated strong concordance with other FDA-approved companion diagnostics and serves as a powerful tool to guide treatment decisions in both adult and pediatric cancer patients. Cancer remains one of the most complex and diverse diseases to treat. With many targeted therapies currently FDA-approved, selecting the right one for a specific patient requires detailed genetic insights. MI Cancer Seek addresses this need by analyzing both DNA and RNA from a single tumor sample. The tool identifies key biomarkers linked to FDA-approved treatments for several major cancers, including breast, lung, colon, melanoma, and endometrial cancers. One of the most significant strengths of MI Cancer Seek is its ability to deliver accurate and reliable results from minimal tissue input (50 ng). Even when analyzing formalin-fixed paraffin-embedded samples, which are widely used but often degraded, the test maintained high levels of accuracy. It successfully detected important genetic alterations such as PIK3CA, EGFR, BRAF, and KRAS/NRAS mutations and measured tumor mutational burden (TMB) and microsatellite instability (MSI), both of which are key indicators for immunotherapy response. In clinical comparisons, the test achieved over 97% agreement with other FDA-approved diagnostic tools, confirming its reliability in detecting critical biomarkers. Notably, it showed near-perfect accuracy in identifying MSI status in colorectal and endometrial cancers. The researchers also demonstrated that the test maintains precision across different lab conditions and varying DNA input levels, confirming its robustness for routine clinical use. Beyond its role as a companion diagnostic, MI Cancer Seek incorporates additional features developed under its predecessor, MI Tumor Seek Hybrid. These include detection of homologous recombination deficiency, structural variants, and cancer-related viruses. It also includes advanced tools such as the Genomic Probability Score for identifying the tissue of origin in cancers of unknown primary, as well as a gene signature to guide first-line chemotherapy in colorectal cancer. “One limitation to be considered is the low PPA for ERBB2 CNA detection.” By offering deeper genetic insights from a single, small sample, MI Cancer Seek has the potential to streamline diagnostics, reduce testing costs, and connect patients to effective therapies more quickly. As precision medicine continues to expand, this assay stands out as a comprehensive and efficient solution for meeting the evolving needs of modern oncology. DOI - https://doi.org/10.18632/oncotarget.28761 Correspondence to - David Spetzler - dspetzler@carisls.com Video short - https://www.youtube.com/watch?v=D4hd2FxCYY8 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Nerve stimulation device cleared for sleep apnea; Skysona safety update; new non-cystic fibrosis bronchiectasis treatment; FDA cracks down on animal-derived thyroid meds; RSV therapy to be discontinued.

What would change if every woman could access birth control without barriers?In this powerful episode of the Women in Leadership Talk podcast, Vicki Bradley speaks with Samantha Miller, Co-Founder & CEO of Cadence OTC, about her groundbreaking work to make the most popular birth control pills available over the counter. Samantha reveals the challenges of navigating FDA red tape, confronting political resistance, and breaking through retail gatekeeping all while advocating for women's right to control their reproductive health.Want to grow as a leader? Explore our FREE leadership quiz and mini-courses at: www.wilempowered.com/free-mini-course

Abdul and Katelyn condemn the violence at the CDC headquarters last week, and the startlingly weak response from lawmakers. Then they unpack Trump's newest executive order, which seeks to give his own appointees the power to approve federal grants. They also discuss the future of the FDA as Vinay Prasad makes his return, following his resignation last month. Then Abdul talks to Sherrell Byrd, founder of SOWEGA Rising, which has organized in rural Georgia to bring fresh produce to rural communities that lack grocery stores. They discuss the health implications of food deserts, and how food justice can change lives. Check out our shop at store.americadissected.com for our new America Dissected merch – including logo shirts, hoodies and mugs. And don't miss our “Vaccines Work. Science Matters.” t-shirts! This show would not be possible without the generous support of our sponsors. America Dissected invites you to check them out. This episode was brought to you by: Quince: Go to Quince.com/AD for free shipping on your order and 365-day returns.

In episode 1914, Miles and guest co-host Pallavi Gunalan are joined by comedian, Shanna Christmas, to discuss… SHUT UP ABOUT EPSTEIN! Trump Now Thinking of Reclassifying Weed…, JD Vance’s Vacation Is The Worst Thing To Happen To The U.K. Since Ellen, There’s A TRIANGLE OF DEATH On Your Face? And more! MAGA Freaks Out Over Trump’s Plot to Reclassify Weed Trump Nemesis Is Bringing Epstein Victims to Capitol to Push for Files Release JD Vance’s English Countryside Vacation: Rolling Hills, Armored SUVs and Cranky Locals JD Vance's motorcade travelling through Chipping Norton. Video by Ed Nix Chaos in the Cotswolds as protests erupt against JD Vance’s holiday in quaint village Anti-JD Vance van drives around Cotswolds as US Vice President holidays in village Ellen DeGeneres clashes with Cotswolds neighbours over extension ‘breach’ at £15m home | The Standard After Being ‘Pushed Out’ of Hollywood, Here’s How Ellen DeGeneres is Starting Over in England (Exclusive) LISTEN: Kneel by Nilüfer YanyaSee omnystudio.com/listener for privacy information.

Looking 4 Healing Radio with Dr. Benjamin Benulis – The overlap between two of the most corrupt systems in America: Big Pharma and Big Ag. We break down how both industries profit by keeping people sick, why the USDA and FDA are basically revolving doors for corporate interests, and how people often wake up to one form of corruption while staying blind to the other...

August 14, 2025Have you had your dose of The Daily MoJo today? Download The Daily MoJo App! "Ep 081425: Time Has Flown | The Daily MoJo"Kellogg's commits to removing artificial food colorings by 2027 due to health concerns, particularly for children. The discussion also touches on various topics, including the cultural impact of the Rocky Horror Picture Show, political commentary, and personal anecdotes about health and community. Plans for a new shop location and a weight loss journey are shared, emphasizing local business support and resilience in personal growth.Phil Bell's Morning Update Is Trump a racist or do these mayors just suck at their job?:  HEREJeff Fisher - Host of Chewing The Fat Podcast - Was nowhere in sight.  Jeff Fisher LinktreeBrandon Morse - Redstate Author & host of The Brandon Morse YouTube channel- Has a great idea - bring back smoking!Brandon's LinktreeOur affiliate partners:Be prepared! Not scared. Need some Ivermection? Some Hydroxychloroquine? Don't have a doctor who fancies your crazy ideas? We have good news - Dr. Stella Immanuel has teamed up with The Daily MoJo to keep you healthy and happy all year long! Not only can she provide you with those necessary prophylactics, but StellasMoJo.com has plenty of other things to keep you and your body in tip-top shape. Use Promo Code: DailyMoJo to save $$Take care of your body - it's the only one you'll get and it's your temple! We've partnered with Sugar Creek Goods to help you care for yourself in an all-natural way. And in this case, "all natural" doesn't mean it doesn't work! Save 15% on your order with promo code "DailyMojo" at SmellMyMoJo.comCBD is almost everywhere you look these days, so the answer isn't so much where can you get it, it's more about - where can you get the CBD products that actually work!? Certainly, NOT at the gas station! Patriots Relief says it all in the name, and you can save an incredible 40% with the promo code "DailyMojo" at GetMoJoCBD.com!Romika Designs is an awesome American small business that specializes in creating laser-engraved gifts and awards for you, your family, and your employees. Want something special for someone special? Find exactly what you want at MoJoLaserPros.com  There have been a lot of imitators, but there's only OG – American Pride Roasters Coffee. It was first and remains the best roaster of fine coffee beans from around the world. You like coffee? You'll love American Pride – from the heart of the heartland – Des Moines, Iowa. AmericanPrideRoasters.com   Find great deals on American-made products at MoJoMyPillow.com. Mike Lindell – a true patriot in our eyes – puts his money where his mouth (and products) is/are. Find tremendous deals at MoJoMyPillow.com – Promo Code: MoJo50  Life gets messy – sometimes really messy. Be ready for the next mess with survival food and tools from My Patriot Supply. A 25 year shelf life and fantastic variety are just the beginning of the long list of reasons to get your emergency rations at PrepareWithMoJo50.comStay ConnectedWATCH The Daily Mojo LIVE 7-9a CT: www.TheDailyMojo.com (RECOMMEDED)Rumble: HEREFacebook: HEREMojo 5-0 TV: HEREFreedomsquare: HEREOr just LISTEN:The Daily MoJo Channel Become a supporter of this podcast: https://www.spreaker.com/podcast/the-daily-mojo-with-brad-staggs--3085897/support.

**

The FDA's Ban on NDT Medications: What You Need to Know Now The FDA has announced a ban will go in effect in one year on Natural Desiccated Thyroid (NDT) medications, including Armour, NP, and compounded thyroid meds. This isn't just about NDT, it could be the first move toward restricting all bioidentical hormone options. In this episode, I break down the FDA letter line-by-line, follow the money trail, and explain why NDT has been the gold standard for decades. I share what's at stake if this ban goes through, why T4-only medications fail most patients, and the critical differences between bioidentical and synthetic options. You'll hear clinical insights from my practice, where thousands have thrived on the right thyroid med combination, and you'll get clear steps for taking action, emailing the FDA, signing petitions, and protecting your right to choose the treatments that work for you. This is your health freedom alert. The decisions made now will affect your weight, energy, hormones, and quality of life for years to come. Sign this Petition: https://chng.it/RwB8mF72tY Subscribe to my Newsletter: https://health.dramie.com/newsletter Contact the FDA: Email: druginfo@fda.hhs.gov - The Division of Drug Information in the Center for Drug Evaluation and Research, specifically for questions about drugs.

This week on Two Parents & A Podcast, we're diving into the benefits of family dinner (we're feeling VALIDATED), baby shower do's and don'ts (including one MAJOR mistake we made), and an in-depth review of the Karen Read trial (yep, you read that right). Before all that… we're in Vancouver!!!! Our FIRST international episode (unless someone digs up that one from the lost files). Harrison rapid-fires his travel recs to help YOU plan your next trip (sorry in advance—he named a chain lol). We also get into how our parents' habits shaped us, the joy of Sunday night dinners, and a new rule that has completely SAVED movie night. Then the fun stuff—our picks for the absolute BEST gifts for new moms (the last one may surprise you). And in Things We DMed: the most attractive (and unattractive) hobbies a man can have, plus… Gen Z is apparently sucking on WHAT?! OK LOVE YOU GUYS!!! 00:00:00 Welcome back to Two Parents & A Podcast! 00:04:02 Rapid-fire Vancouver recommendations for your next trip 00:07:05 Our craziest airport horror stories 00:12:32 How your parents' habits shape who you are today 00:14:40 Sunday night family dinner 00:20:15 Our thoughts on the Karen Read trial 00:27:15 New rule that solved our movie night problem 00:31:46 Baby shower do's and don'ts 00:37:33 The absolute best gifts for new moms 00:47:45 The most attractive (and unattractive) hobbies a man can have 00:52:00 Gen Z's new anxiety trend: PACIFIERS?!  00:52:50 #1 parenting hack: family dinners 00:55:08 THANK YOU FOR LISTENING!!!  #twoparentsandapod --------------------------------------------------------------- Thank you to our sponsors this week: Hers: Start your initial free online visit today at https://www.forhers.com/ALEX for your personalized weight loss treatment options. Hers Weight Loss is not available everywhere. Compounded products are not FDA-approved or verified for safety, effectiveness, or quality. Prescription required. Restrictions apply. Wegovy® and Ozempic® are not compounded. Actual price depends on product and plan purchased. Cozy Earth: Head to https://www.CozyEarth.com and use code TWOPARENTS for up to 40% off! And if you get a Post-Purchase Survey, make sure to let them know you heard about Cozy Earth right here!  Quince: Give your summer closet an upgrade—with Quince. Go to https://www.Quince.com/Alex for free shipping on your order and three hundred and sixty-five-day returns.  --------------------------------------------------------------- Listen to the pod on YouTube/Spotify/Apple: https://www.youtube.com/@twoparentsandapod https://open.spotify.com/show/7BxuZnHmNzOX9MdnzyU4bD?si=5e715ebaf9014fac https://podcasts.apple.com/us/podcast/two-parents-a-podcast/id1737442386 --------------------------------------------------------------- Follow Two Parents & A Podcast: Instagram | https://www.instagram.com/twoparentsandapod TikTok | https://www.tiktok.com/@twoparentsandapod Follow Alex Bennett: Instagram | https://www.instagram.com/justalexbennett TikTok | https://www.tiktok.com/@justalexbennett Follow Harrison Fugman: Instagram | https://www.instagram.com/harrisonfugman TikTok | https://www.tiktok.com/@harrisonfugman --------------------------------------------------------------- Powered by: Just Media House – https://www.justmediahouse.com/ --------------------------------------------------------------- Learn more about your ad choices. Visit megaphone.fm/adchoices

Is the FDA phasing out natural thyroid?Study:  Lithium for Alzheimer's diseaseMore on water filtration issuesMy mother-in-law has hallucinations when she has a UTI.  Why is that?Are dental mouth guards toxic?  Is there a better alternative for clenching and bruxism?

TODAY ON THE ROBERT SCOTT BELL SHOW: FDA's Dr. Prasad Returns, Gut Health Illness Connection, The Boomer Mirage, ChatGPT Bad Health Advice, Lachnanthes Tinctoria, FDA to end EUA, Laurie Hammer, Calm Mom Method, Comment of the Day, Medicaid Vax Rush and MORE! https://robertscottbell.com/fdas-dr-prasad-returns-gut-health-illness-connection-the-boomer-mirage-chatgpt-bad-health-advice-lachnanthes-tinctoria-fda-to-end-eua-laurie-hammer-calm-mom-method-comment-of-the-day-medic/ https://boxcast.tv/view/fdas-dr-prasad-returns-gut-health-illness-connection-the-boomer-mirage-laurie-hammer-calm-mom-method---the-rsb-show-8-13-25-b5frzcmphayesomqybg2 Please read this disclaimer carefully before you (“you”, “your”) use our [Your Website URL] website (“website”, “service”) operated by the [Your Business Name] (“operator”, “us”, “we”, “our”). Purpose and Character The use of copyrighted material on the website is for non-commercial, educational purposes, and is intended to provide benefit to the public through information, critique, teaching, scholarship, or research. Nature of Copyrighted Material Weensure that the copyrighted material used is for supplementary and illustrative purposes and that it contributes significantly to the user's understanding of the content in a non-detrimental way to the commercial value of the original content. Amount and Substantiality Our website uses only the necessary amount of copyrighted material to achieve the intended purpose and does not substitute for the original market of the copyrighted works. Effect on Market Value The use of copyrighted material on our website does not in any way diminish or affect the market value of the original work. We believe that our use constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the U.S. Copyright Law. If you believe that any content on the website violates your copyright, please contact us providing the necessary information, and we will take appropriate action to address your concern.

Looking 4 Healing Radio with Dr. Benjamin Benulis – The overlap between two of the most corrupt systems in America: Big Pharma and Big Ag. We break down how both industries profit by keeping people sick, why the USDA and FDA are basically revolving doors for corporate interests, and how people often wake up to one form of corruption while staying blind to the other...

In this two-part interview, Dr. Peter Thorne, University of Iowa Distinguished Chair and Professor of Occupational and Environmental Health and a leading expert in toxicology, provides an in-depth overview of how the federal government regulates chemicals in food, water, and air. Key points: • The EPA and FDA are science-based organizations that interpret laws passed by Congress and apply the best available science to make regulatory decisions aimed at protecting human health and the environment. • The EPA's Science Advisory Board provides independent, non-partisan oversight to ensure the agency's decisions are grounded in scientific evidence. • Chemical regulations are dynamic, with compounds like Red Dye No. 3 and inorganic arsenic being re-evaluated as new scientific data emerges. • The precautionary principle guides regulators to err on the side of safety when the evidence suggests a chemical may pose health risks, even in the absence of definitive human studies. • Replacing problematic chemicals with safer alternatives can facilitate regulatory action, though the availability of substitutes should not be the primary driver of these decisions. • Persistent organic pollutants like PCBs and PFAS pose complex public health challenges due to their ubiquity and long-lasting environmental presence, underscoring the need for continued research and policy responses. A transcript of this episode will be available soon. Have a question for our podcast crew or an idea for an episode? You can email them at CPH-GradAmbassador@uiowa.edu You can also support Plugged in to Public Health by sharing this episode and others with your friends, colleagues, and social networks. #publichealth #environmentalhealth #toxicology #climatechange

"Burnout and trauma are not mental illnesses. They live in your physiology. They live in your biology. They live very specifically in your nervous system,” Dr. Rola Hallam says with a conviction rooted in her own successful journey to overcome the effects of chronic stress she accumulated during many years on the frontlines of humanitarian crises in Syria and other conflict zones. Out of concern for the multitudes of health professionals who, like herself, spend years carrying the weight of their traumatic experiences without seeking help, or who pursue ineffective remedies for relieving it, Dr. Rola -- as she's known – has shifted her focus to being a trauma and burnout coach. Among her offerings is Beyond Burnout, a twelve-week program that includes multimedia content as well as live coaching and teaching about developing nervous system awareness and regulation. “Most wellness initiatives fail because they're not rewiring the nervous system to come out of survival mode and back into what is called the ventral-vagal state, which is our state of social connection and of healing and repair.” She also stresses that healing is not an individual pursuit, especially for providers who work in a relational field, and teaches about the benefits of borrowing from a colleagues' state of calm and offering them the same. Don't miss this insightful and giving conversation with host Lindsey Smith that covers Dr. Rola's wrenching experiences providing care in desperate conditions, the critically important distinction between empathy and compassion, and how empowering frontline workers to heal their trauma can uplift individuals and empower entire communities. Mentioned in this episode:Dr. Rola CoachingBeyond Burnout AssessmentCanDo - Humanitarian Aid If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

What is hidradenitis suppurativa (HS)? Why is it often misdiagnosed, and what does effective care look like? We spoke to Jennifer L. Hsiao, MD, dermatologist and director of the Hidradenitis Suppurativa Specialty Clinic at USC, to break down what HS really is, why a multidisciplinary team matters, and how new treatments, including FDA-approved biologics, are changing the landscape. We also hear from Athena Gierbolini, president of Hope for HS, who shares her 14-year journey with HS, from painful trial-and-error treatments to finding life-changing support and specialist care. Join us as we learn how to advocate for better care and find the right resources to manage this complex and chronic condition.See omnystudio.com/listener for privacy information.

Have you ever wondered if your body's energy could be the missing link to true healing? Today, Dr. Robert Whitfield speaks with Harry Massey, a true trailblazer in bioenergetics. Harry's story is nothing short of incredible; from being bedridden with a chronic illness to inventing cutting-edge, energy-based health technologies that are changing lives. We delve into the fascinating science of bioenergetics, examining why your emotional well-being is just as crucial as your physical health. Tune in to hear more! Bio: Harry Massey Harry Massey is a globally recognized expert in bioenergetics, the science that examines the energy in living systems. As the founder of NES Health, XPO Health, and Energy4Life, he has developed groundbreaking technologies, including the FDA-cleared miHealth device, infoceuticals, and the Bioenergetic WellNES System, to help people restore their energy, health, and vitality. Harry is also the producer of the award-winning documentary "The Living Matrix" and the creator of the GIST Process, a system for mastering energy to transform one's life. Through his Institute of Bioenergetics, he continues to advance research and public education in partnership with UC San Diego. HarryMassey.com (http://HarryMassey.com) Energy 4 Life (https://www.e4l.com/) E4l.comrob (https://www.e4l.com/rob) Facebook (https://www.facebook.com/harry.massey1/?kuid=1efb244d-e226-437d-988c-0c7ea1e208d7-1750814129&kref=https%3A%2F%2Fwww.harrymassey.com%2Fwho-is-harry-massey%2F) Instagram (https://www.instagram.com/harrymasseyofficial/?kuid=1efb244d-e226-437d-988c-0c7ea1e208d7-1750814129&kref=https%3A%2F%2Fwww.harrymassey.com%2Fwho-is-harry-massey%2F) YouTube (https://www.youtube.com/channel/UCt-AsCVcd6LIOtTTOPb6iSQ) Show Highlights: Harry's Illness and Journey to Bioenergetics (00:02:22) Harry recounts his climbing accident, subsequent illness, and years of being bedridden. Bioenergetics vs. Biochemistry (00:07:58) Discussion on whether healing focuses on mitochondria, and the need to address all body systems, not just one. Physics and Biophysics in Healing (00:10:18) Transition from traditional chemistry-based views to physics and field-based understanding of body control systems Suppression of Energy Medicine (00:15:01) Historical context on the suppression of energy medicine and the dominance of pharmaceuticals Principles of Bioenergetics & Body Battery (00:18:52) Concept of the body battery, cellular energy, and strategies for energy regeneration and efficiency. Emotional States and Disease (00:22:25) How negative emotions drain energy and contribute to disease, and how their wearables address this Mindset and Healing (00:24:46) Discussion on the importance of mindset, emotional support, and the role of AI and journaling Pain Management Technologies (00:29:33) Introduction of the MIHealth device, its mechanisms for pain relief, and the use of red light therapy Links and Resources Podcast: https://podcasts.apple.com/gb/podcast/breast-implant-illness/id1678143554 Spotify: https://open.spotify.com/show/1SPDripbluZKYsC0rwrBdb?si=23ea2cd9f6734667 TikTok: https://www.tiktok.com/@drrobertwhitfield?t=8oQyjO25X5i&r=1 IG: https://www.instagram.com/breastimplantillnessexpert/ FB: https://www.facebook.com/DrRobertWhitfield Linkedin: https://www.linkedin.com/in/dr-robert-whitfield-md-50775b10/ X: https://x.com/rob_whitfieldmd Read this article: https://www.breastcancer.org/treatment/surgery/breast-reconstruction/types/implant-reconstruction/illness/breast-implant-illness Shop: https://drrobssolutions.com SHARP: https://www.harp.health NVISN Labs - https://nvisnlabs.com/ Get access to Dr. Rob's Favorite Products below: Danger Coffee - Use our link for mold free coffee - https://dangercoffee.com/pages/mold-free-coffee?ref=ztvhyjg JASPR Air Purifier - Use code DRROB for the Jaspr Air Purifier - https://jaspr.co/ Echo Water - Get high quality water with our code DRROB10 - https://echowater.com/ BallancerPro - Use code DRROBVIP for the world's leader in lymphatic drainage technology - https://ballancerpro.com Ultrahuman - Use code WHITFIELD10 for the most accurate wearable - https://www.ultrahuman.com/ring/buy/us/?affiliateCode=drwhitfield

Joe Pags takes you through a whirlwind of today's biggest headlines—from Melania Trump suing Hunter Biden to President Trump's upcoming meeting with Russian President Vladimir Putin this Friday. Pags gives you the straight truth, cutting through the noise and delivering the facts you need. Then, Dr. Jesse Lopez joins the show to reveal jaw-dropping details about the Department of Health and Human Services, including his claim that 73% of FDA-approved medications may not actually work for their intended purpose. You won't want to miss this explosive mix of politics, global news, and hard-hitting medical revelations. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode 2683 - Vinnie Tortorich and Chris Shaffer discuss advertising, the Beyond Meat rebranding, and how a better diet means better results, and more. https://vinnietortorich.com/2025/08/better-diet-means-better-results-episode-2683 PLEASE SUPPORT OUR SPONSORS   YOU CAN WATCH THIS EPISODE ON YOUTUBE - A Better Diet Means Better Results The Billy Joel documentary is super-engaging. (2:00) It's on HBO Max, and you must have an HBO Max account if you want to view it on Amazon. The documentary is in two parts and is called “Billy Joel: And So It Goes.” Vinnie addresses the Sydney Sweeney American Eagle jeans ad. (10:45) The outcry on social media appears to be unfounded. Beyond Meat has made a branding change and has shortened its name to just “Beyond.” (29:00) Vinnie's documentary “Beyond Impossible” addresses issues with fake meat. They discuss other fake foods and ingredients, including JUST “eggs.” (32:15) The FDA allows marketing on labels to include misinformation. Proteins from things like legumes are not equal to the complete amino acids and ratios of animal protein. (38:00) They review the “new and improved” recipe by Beyond. (40:00) Pure Coffee Club has a fun announcement. (42:00) Vinnie understands what it means to be overweight, eat cheap foods, and have a sugar addiction. (48:30) There's a revelation about changes to some brands of canned tuna. (52:00) They discuss an article in Sports Illustrated that states that exercise helps with weight loss. There needs to be clarification: weight loss doesn't happen unless you're eating the proper diet. (55:00) Eating the proper ratio of fat and protein will magnify weight loss. Exercise alone while eating a ton of carbs will not help your body burn fat for weight loss. The article was trying to emphasize that if you are on a diet, the more you exercise, the less muscle you lose, which helps your metabolism. (58:15) A better diet means better results. In the 1950s, people were often leaner because we were a less sedentary society. (1:00:00) More News If you are interested in the NSNG® VIP group, it will be reopening soon. But you can get on the wait list - Don't forget to check out Serena Scott Thomas on Days of Our Lives on the Peacock channel.  “Dirty Keto” is available on Amazon! You can purchase or rent it . Make sure you watch, rate, and review it! Eat Happy Italian, Anna's next cookbook, is available!  You can go to  You can order it from .  Anna's recipes are in her cookbooks, website, and Substack–they will spice up your day!  Don't forget you can invest in Anna's Eat Happy Kitchen through StartEngine.  Details are at Eat Happy Kitchen.    PURCHASE  DIRTY KETO (2024) The documentary launched in August 2024! Order it TODAY! This is Vinnie's fourth documentary in just over five years. Visit my new Documentaries HQ to find my films everywhere:  Then, please share my fact-based, health-focused documentary series with your friends and family. Additionally, the more views, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! PURCHASE BEYOND IMPOSSIBLE (2022) Visit my new Documentaries HQ to find my films everywhere:  REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! FAT: A DOCUMENTARY 2 (2021) Visit my new Documentaries HQ to find my films everywhere:  FAT: A DOCUMENTARY (2019) Visit my new Documentaries HQ to find my films everywhere: 

Marsha was nearly killed in a fatal plane crash, yet for her, the experience has turned out great HERS Thank you, HERS!  forhers.com/SECRET for your personalized weight loss treatment options. Hers Weight Loss by Hers is not available everywhere. Compounded products are not approved or reviewed for safety, effectiveness, or quality by the FDA. Prescription required. See website for full details, important safety information, and restrictions. Actual price depends on product and plan purchased. HOME CHEF For a limited time, get 50% off and free shipping for your first box PLUS free dessert for life!  HomeChef.com/SECRET.  Must be an active subscriber to receive free dessert. MINT MOBILE Get this new customer offer and your 3-month Unlimited wireless plan for just $15 a month at  MINTMOBILE.com/SECRET. PICTURES See Marsha, her daughter, Naomi, Liz, the restaurant and the crash on social They are waiting for you on Threads, Facebook, Instagram and X.  Handle: @secretroompod. THE SECRET ROOM | UNLOCKED Zach's family has memories from his high school graduation and even talk about how he looked in his cap and gown. The only thing is he never graduated. Tune in to find out the story of how Zach got his GED and nobody knows. Host: Susie Lark. The Secret Room | Unlocked is yours when you support your favorite indie podcast that could with a membership at patreon.com/secretroom, Apple Podcasts or Spotify. There's a free trial! ALL OUR SPONSORS See all our sponsors past and present, and their offers, many of which are still valid: secretroompodcast.com/codes  FACEBOOK DISCUSSION GROUPThere's even more fun at The Secret Room Podcast Facebook Discussion Page!  Just ask to join, all are welcome. :) YOUR SECRET  Click "Share a Secret" at secretroompod.com! PODCAST TEAM Producer: Susie Lark. Story Development: Luna Patel. Music and Theme: Breakmaster Cylinder. LISTENER SURVEY Take our Listener Survey at SecretRoomPod.com!

The 5 things you need to know before the stock market opens today: the White House is still working out the details of President Trump's plan to charge 15% export taxes on chipmakers' business in China, OpenAI's Sam Altman is working on a Neuralink competitor, the FDA is considering revoking authorization for Pfizer's Covid-19 vaccine for healthy children under age 5, Circle announced a new stock offering and a U.S. base in Anchorage is preparing to host the upcoming Trump-Putin Alaska summit.  Squawk Box is hosted by Joe Kernen, Becky Quick and Andrew Ross Sorkin.  Follow Squawk Pod for the best moments, interviews and analysis from our TV show in an audio-first format. 

On this episode of Vitality Radio, Jared welcomes back herbalist and educator Jamie Cotter from WishGarden Herbs to explore their line of natural solutions for pregnancy, babies, and nursing. From organic baby oils and diaper balms to pregnancy support and breastfeeding essentials, Jamie shares how these thoughtfully crafted, botanical formulas nurture skin, encourage milk supply, and promote overall well-being—without harsh chemicals or synthetic fragrances. You'll hear about must-have remedies like Ear Be Well for ear health, Milk Rich for healthy lactation, and Happy Ducts for maintaining breast comfort. Learn how these products fit into a natural “medicine cabinet” approach that supports families in staying prepared, avoiding unnecessary pharmaceutical interventions, and using herbs as a first line of defense.Wishgarden Mom & Baby ProductsTerry Naturally Energy Revitalization (Vitality Radio POW! Product of the Week 40% off with PROMO CODE: POW4)Visit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.

Can stem cells help your body heal itself? Dr. Joy Kong thinks so. And she's got the science (and patient case studies) to prove it. From hospice recoveries to straightened spines, her work in regenerative medicine is redefining what's possible when we stop over-relying on traditional medicine and start activating the potential already within our bodies. You'll walk away from this episode with a grounded understanding of what stem cells actually do, how to spot hype and breakthrough the myths, and which simple, accessible habits can reignite your body's regenerative powers.   What You'll Learn: 02:52 A dying man walks again, Dr. Kong's wildest patient transformation 05:13 The 7 powerful ways stem cells repair your body 10:42 The 3 biggest myths about stem cell therapy 19:51 What “ethically sourced stem cells” really means 37:39 One small thing you can do today to start healing naturally Today, Ginni welcomes Dr. Joy Kong, a trained psychiatrist and leader in regenerative medicine, to talk about why she pivoted from traditional psychiatry into the world of stem cells. She shares wild success stories from her clinic, breaks down the biological science behind healing, and gets candid about the backlash, red tape, and systemic suppression that has tried to slow down the field. You'll hear about Dr. Kong's take on the misunderstood world of energy medicine, why walking in nature might beat your antidepressant, and what your sugar addiction is really doing to your cells. From ethical sourcing to FDA confusion, this conversation demystifies what stem cells are, what they aren't, and why you may be hearing a lot more about them in the future. Connect with Dr. Joy Kong: Website: https://joykongmd.com/ Instagram: https://www.instagram.com/dr_joy_kong/ LinkedIn: https://www.linkedin.com/in/joy-kong-md-4b8627123/ YouTube: https://www.youtube.com/@joykongmd Connect with Ginni: Website: https://ginnisaraswati.com/ Instagram: https://www.instagram.com/theginnishow/ LinkedIn: https://www.linkedin.com/in/ginnisaraswati Ginni Media: www.ginnimedia.com Got a great show topic idea? A guest you'd love to see on the Ginni Show? Tell us about it: (844) 543-1772

This episode is brought to you by Cozy Earth, one of HeHe's favorite things to have on hand for a comfy pregnancy and postpartum period! Use code HEHE for 40% off the softest PJ's, loungewear, or even new sheets to make your pregnancy and postpartum feel a little more luxurious. Grab The Secret Sauce to Pushing Here or join our lifetime membership to get free access!  In this episode of The Birth Lounge Podcast, I'm sitting down with Whitney and Brandon Cawood to uncover the hidden ways synthetic food dyes can impact your child's health and behavior. We're talking real-life symptoms like irritability, hyperactivity, sleep struggles, and even aggression — and the science that backs it up. Whitney and Brandon share their powerful story of discovering their son's sensitivity to dyes, the huge transformation they saw after removing them, and how that journey turned into advocacy work. We're pulling back the curtain on industry resistance, why the FDA has been slow to act, and what legislation is (and isn't) doing to protect families. You'll get practical tips for spotting dyes in your pantry, finding dye-free swaps, and trusting your gut when it comes to your child's health — even if the experts say otherwise. This is your crash course in advocating for your kids, one grocery trip at a time. Timestamps 00:00 Introduction to Synthetic Dyes and Their Effects 01:07 Welcome to The Birth Lounge Podcast 01:37 The Secret Sauce to Pushing Course 02:00 Understanding the Anatomy of Pushing 04:06 Challenges in the Hospital System 05:26 A World Without Synthetic Food Dyes 07:17 How Synthetic Dyes Affect Children 10:24 The Cawood Family's Story 17:12 Raising Awareness & Building Community 31:06 Genetics & Dye Sensitivity 34:35 The Push for Legislation & Safer Alternatives 37:03 The Health Toll of Synthetic Dyes 38:11 FDA Inaction & Public Pressure 41:23 Fighting for Education & Awareness 45:51 Barriers for Low-Income Families 48:14 Removing Harmful Chemicals from Daily Life 50:51 Why They Made a Documentary 52:25 Trust Issues with Regulatory Agencies 54:54 How Prevalent Synthetic Dyes Really Are 01:02:36 Easy Dye-Free Swaps 01:05:14 Industry Resistance to Change 01:07:55 State Efforts & Corporate Pushback 01:09:10 Empty Corporate Promises 01:12:25 The Worst Offending Dyes 01:17:42 Decoding Dye Labels 01:23:33 Parental Advocacy in a Broken System 01:31:54 Resources & Final Thoughts BIO: After discovering their child's sensitivity to synthetic dyes, Brandon and Whitney Cawood, parents-turned-filmmakers, embarked on a journey to uncover the hidden impacts of these additives. Their documentary combines scientific insights and personal stories from affected families, revealing the unseen dangers of synthetic dyes. Through expert interviews and heartfelt narratives, the Cawoods aim to raise awareness of the profound effects these chemicals can have on individuals and families alike. Since beginning this journey, they've also become national advocates, working on legislation across the U.S. to help protect children from harmful food additives. INSTAGRAM: Connect with HeHe on IG  Connect with HeHe on YouTube   Connect with To Dye For on IG    BIRTH EDUCATION: Grab The Secret Sauce to Pushing Here!    Join The Birth Lounge here for judgment-free childbirth education that prepares you for an informed birth and how to confidently navigate hospital policy to have a trauma-free labor experience!   Download The Birth Lounge App for birth & postpartum prep delivered straight to your phone!   LINKS MENTIONED: https://www.todyeforthedocumentary.com/   Keywords: synthetic food dyes, food dye effects on children, red dye 40 side effects, red 3 ban, hyperactivity and food dyes, dye free diet for kids, artificial food coloring dangers, parenting and food dyes, dye sensitivity in children, natural food dye alternatives, removing food dyes from diet, FDA and synthetic dyes, dye free living tips, birth lounge podcast, Whitney and Brandon Cawood interview

What if we could finally crack the code on treating brain cancer by opening the door that's blocked 98% of therapies? In this episode, Dr. Michael Canney, Chief Scientific Officer of Carthera, reveals how SonoCloud—a revolutionary ultrasound implant—temporarily opens the blood-brain barrier to deliver chemotherapy directly to tumors like glioblastoma. With over 100 patients enrolled in a Phase III trial across 40 global sites, this isn't just a bold idea—it's happening now. Michael also shares real-world lessons in scaling trials, FDA navigation, and aligning science with commercial success. If you're passionate about disruptive innovation in neuro-oncology, you'll want to hear how Carthera is changing the game.

SPONSOR: RELIEFBAND - If you deal with nausea, Reliefband is a breakthrough you need to know about. It’s the original anti-nausea wristband that quickly relieves and effectively prevents nausea and vomiting, without the use of drugs or drowsy side effects. You simply wear it on your wrist, adjust the intensity depending on how you’re feeling, and within minutes, it starts working. The new Premier Plus model even includes a digital clock and smart skin sensing technology to help preserve battery life. It’s FDA - cleared technology originally developed for hospital use. If you want to cure your nausea problem FAST, join the hundreds of thousands of people who are nausea free with Reliefband. Right now, there’s an exclusive offer just for listeners of the Rick Burgess Show - If you go to https://www.Reliefband.com and use promo code “RICKB” you’ll receive 20% off, plus free shipping!See omnystudio.com/listener for privacy information.

SPONSOR: RELIEFBAND - If you deal with nausea, Reliefband is a breakthrough you need to know about. It’s the original anti-nausea wristband that quickly relieves and effectively prevents nausea and vomiting, without the use of drugs or drowsy side effects. You simply wear it on your wrist, adjust the intensity depending on how you’re feeling, and within minutes, it starts working. The new Premier Plus model even includes a digital clock and smart skin sensing technology to help preserve battery life. It’s FDA - cleared technology originally developed for hospital use. If you want to cure your nausea problem FAST, join the hundreds of thousands of people who are nausea free with Reliefband. Right now, there’s an exclusive offer just for listeners of the Rick Burgess Show - If you go to https://www.Reliefband.com and use promo code “RICKB” you’ll receive 20% off, plus free shipping!See omnystudio.com/listener for privacy information.

Presented by Happy Dad Hard Seltzer. Find Happy Dad near you http://happydad.com/find (21+ only). Video is available on https://youtube.com/@onenightwithsteiny/videos. Follow Steiny on Instagram http://instagram.com/steiny. Get harder, longer-lasting erections with Ro Sparks: $15 off first order of medication to get hard at http://ro.co/steiny Compounded drugs are permitted to be prescribed under federal law but are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review by the FDA. For full safety information, go to http://ro.co/steiny Part of the Shots Podcast Network (shots.com). You can listen to the audio version of this podcast on Spotify, Apple Podcasts & anywhere you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices